Nanomedicine: Challenges and Promises for Public Health Future
DOI:
https://doi.org/10.61841/xd72y607Keywords:
Environmental Health, Epidemiology, Nanomedicine, Nanotechnology, Public Health, VaccinationAbstract
With the advancement of the scope applications of nanotechnology in medicine, it is important to identify and advance relevant contributions to public health at the same time. A broad range of nanomedicine advances promise to affect each medical specialty and reveal new ways to improve efficiency and prolong the lifetime-these improvements can be calculated at both population and individual levels. For instance, combined heart disease and cancer make up roughly half of all deaths, and developments in nanomedicine now show great potential to reduce morbidity and mortality rates related to these diseases. Meanwhile, the public health nanomedicine applications such as portable and rapid diagnostics and more efficient vaccinations have the ability to transform global health. Innovative science in fields such as biology, engineering, medicine, and public health will work together to achieve maximum possible health impacts for populations and individuals. In addition, gaps in information regarding the possible health and safety effects of exposure to the engineered nanomaterials need to be discussed and vigorously explored. Nanomedicine will be powered by innovative, constructive and socially responsible work as it plays an increasingly important and disruptive role in 21st century in medicine and public health.
Downloads
References
[1] V. I Bhardwaj and R. Nikkhah-Moshaie, “Nanomedicine,” in Advances in Personalized I Nanotherapeutics, 2017.
[2] D. Chen and N I. K. Jha, “Introduction to nanotechnology,” Nanoelectronic Circuit I Design. 2011.
[3] H. Boulaiz et al., “I Nanomedicine: Application areas and development prospects,” I International Journal of Molecular Sciences, vol. 12, no. 5. pp. 3303–3321, May-2011.
[4] M. Pautler and S. I Brenner, “Nanomedicine: Promises and challenges for the future I of public health,” Int. J. Nanomedicine, 2010.
[5] P. Kostkova, I “Public health,” in Twitter: A Digital I Socioscope, 2015.
[6] S. Shishkin, I “Health care,” in Russia: Strategy, Policy and I Administration, 2017.
[7] A. Wicki, D I. Witzigmann, V. Balasubramanian, and J. Huwyler, “Nanomedicine in cancer I therapy: Challenges, opportunities, and clinical applications,” Journal of Controlled Release. 2015.
[8] T. Faunce and A. I Watal, “Nanosilver and global public health: International regulatory issues,” I Nanomedicine. 2010.
[9] P. Satalkar, B I. S. Elger, and D. M. Shaw, “Defining Nano, Nanotechnology and Nanomedicine: I Why Should It Matter?,” Sci. Eng.Ethics, 2016.
[10] M. Noury and I J. López, “Nanomedicine and personalised medicine: understanding the I personalisation of health care in the molecularera,” Sociol. Heal. Illn., 2017.
[11] E. Nance, I “Careers in nanomedicine and drug delivery,” Advanced Drug I Delivery Reviews. 2019.
[12] J. P. A. Ioannidis, B. I Y. S. Kim, and A. Trounson, “How to design preclinical studies in I nanomedicine and cell therapy to maximize the prospects of clinical translation,” Nat. I Biomed. Eng., 2018.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
